BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25

• Press Releases

  Cyllene Therapeutics Appoints Seasoned Biotech Executive Dr Marc Grasso as Chief Financial Officer

  September 17, 2026

   · 

  3 min read
• Press Releases

  Orbis Medicines Enters Multi-Target Drug Discovery Partnership with Novo Nordisk Worth up to USD 1.4 Billion

  September 17, 2026

   · 

  4 min read
• Press Releases

  Altis Labs Raises US$25 Million Series A Co-Led by OrbiMed and Qiming Venture Partners USA to Accelerate Clinical Development with AI Endpoints

  September 17, 2026

   · 

  3 min read
• Press Releases

  Altis Labs AI Imaging Endpoint Predicts Overall Survival Benefit in Phase 3 Lung Cancer Trial: Data Presented at IASLC WCLC 2026

  September 17, 2026

   · 

  4 min read
• 

  Cardiovascular disease

  Longeveron’s shares crash as stem cell therapy flunks mid-stage cardio trial

  With just over $10 million in cash available to fuel operations through the end of the year, Longeveron is undertaking a strategic review after the failure of a cardiovascular study.

  September 17, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine

  September 17, 2026

   · 

  6 min read
• Press Releases

  Fennec Pharmaceuticals Announces Oral Presentation of Detailed Results from Investigator-Initiated Phase 2 STS-J01 Clinical Study of Pedmark® in Japan at SIOP 2026

  September 17, 2026

   · 

  14 min read
• Press Releases

  Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer

  September 17, 2026

   · 

  11 min read
• Press Releases

  Medartis Group acquires M.A.R.C. Institute to establish its first surgical education center in the US

  September 17, 2026

   · 

  4 min read
• Press Releases

  SignaBlok Awarded NIH NIDDK Grant to Develop Novel TREM-1 Antagonist Drug for Inflammatory Bowel Disease

  September 17, 2026

   · 

  1 min read